Visium Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-4,200
Closed -$249K 609
2015
Q3
$249K Buy
4,200
+600
+17% +$38.1K ﹤0.01% 735
2015
Q2
$240K Sell
3,600
-38,860
-92% -$2.56M ﹤0.01% 906
2015
Q1
$2.74M Buy
42,460
+38,360
+936% +$2.4M 0.04% 365
2014
Q4
$243K Buy
+4,100
New +$231K ﹤0.01% 930
2014
Q3
Sell
-5,490
Closed -$266K 1048
2014
Q2
$266K Buy
5,490
+1,518
+38% +$74.8K ﹤0.01% 910
2014
Q1
$207K Buy
+3,972
New +$211K ﹤0.01% 791

Other funds holding BMY

Visium Asset Management's BMY Position: Q4 2015 in Review

Visium Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 4,200 shares — an estimated $249K sold.

Visium Asset Management first reported a position in BMY in Q1 2014 and held it in 6 quarters. The position peaked at $2.74M in Q1 2015. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

  • Visium Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
  • Visium Asset Management sold 4,200 Bristol-Myers Squibb shares in Q4 2015, an estimated $249K.
  • Visium Asset Management first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 6 quarters.
  • Visium Asset Management's Bristol-Myers Squibb position peaked at $2.74M in Q1 2015.
  • 1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.